Close

Allmpus Laboratories Embraces Local Manufacturing of Pharmaceutical Essentials

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Oncology start-ups urged to apply and accelerate their business with Discovery Spark

Applications open for Discovery Park’s oncology themed ‘Discovery...

2025 AI Trends & Pharma Predictions

As we navigate what the future of healthcare will...

Swiss Airtainer reaches major milestone with successful completion of first 50 commercial shipments

Swiss Airtainer is pleased to announce the successful completion of its first 50 commercial shipments of high-value life science...

Allmpus Laboratories, one of India’s leading research-based pharmaceutical enterprise, is turning to local manufacturing for Pharma essentials. The initiative is taken to localise supply networks and reduce dependency on other countries for raw materials and Active Pharmaceutical Ingredients (APIs) so as to make the Indian healthcare self-reliant.

India is the third-largest pharmaceuticals market with exports standing at $19 billion in 2019. However, 90% of its raw materials and APIs are still sourced from other countries, two-thirds of which are procured from China itself. Amid the lockdown, the industry faced vast supply chain challenges with non-availability of resources severely impacting the Indian Pharmaceuticals ecosystem.

In the post-pandemic world, Indian pharmaceutical manufacturers have the opportunity to establish a robust supply network and capture a respectable market share. Pharmaceuticals and other essential sectors are expected to see a drastic rise in demand, as high as 200 times to be precise.

Allmpus Laboratories is working to increase its capacity and shift their focus from pharmaceutical impurity standard or drug standard to extensive R&D and reinforce its portfolio with diverse pharma related products.

Present on the occasion, Dr Atish Rodge, Managing Director, Allmpus Laboratories said, “Allmpus is looking at the pandemic as an opportunity in Pharma and other essential sectors. We are actively working to reduce raw material dependency on other countries. Previously, the Indian pharma market was operating on the value-added model of sourcing from other countries and selling the drugs to the world but due to the pandemic this model needs a massive step up. We are planning to start formulation work in the fourth quarter of the financial year specifically focusing on raw material and APIs.”

“We are expecting revenue growth of five times due to increased demand for domestic raw materials and APIs in following months”, he added.

About Allmpus Laboratories

Allmpus laboratories private limited is a research-based pharmaceutical company which can provide flexible solutions to customer’s business through science and innovation. We are providing a Right Product/Service to Right Customer at Right Time which helps us to make a long-term relationship with our client. Today Allmpus has made his place in the market due to extensive product catalogues, Quality, On-Time Delivery, Technical support and Best Price.

Latest stories